Magnesium
A mineral with respectable evidence for blood pressure in the people who are already hypertensive or low in it, weak evidence for sleep, and a clear negative result for the leg cramps it is most often sold to treat 12.
Last scientifically reviewed: November 22, 2026Editorial review: MDS Labs. External scientific review pending.
Commercial disclosure. MDS Labs sells a magnesium glycinate supplement. Everything on this page applies to it, including the Cochrane finding on cramps.
- Common names
- Magnesium; on labels magnesium glycinate, citrate, oxide, malate, threonate or chloride
- Source
- Diet: green leafy vegetables, nuts, seeds, legumes and whole grains
- Part used
- Not applicable: an essential mineral
- Key constituents
- Elemental magnesium. The salt named on the label determines how much elemental magnesium a capsule actually provides and how well it is tolerated
- Classification
- Essential mineral and enzyme cofactor
- Traditional use
- Magnesium salts have a long history of use as laxatives and antacids
- US regulatory status
- Dietary supplement; some magnesium salts are also regulated as over-the-counter laxatives and antacids
Human evidence, outcome by outcome
Graded per outcome. A strong result for one outcome says nothing about another.
Blood pressure in hypertensive people on medication, or people with low blood magnesium
Limited human evidenceSystolic blood pressure fell by 7.68 mmHg in hypertensive people taking blood-pressure medication and by 5.97 mmHg in those with low blood magnesium, against an overall average of 2.81 mmHg 1.
Studied: 38 randomized trials, 2,709 participants, elemental magnesium from 82 to 637 mg daily with a median of 365 mg, median duration 12 weeks.
Limits: Heterogeneity between trials was high and no dose-response relationship was identified, so the size of the effect is less settled than the direction 1.
Blood pressure in people who are not hypertensive
Evidence againstIn normotensive groups the blood-pressure reduction did not reach statistical significance 1.
Studied: Subgroup analysis within the same 38 trials.
Limits: This is the deficit pattern that runs through the whole Lab: the effect appears where something is already wrong.
Preventing idiopathic and nocturnal leg cramps
Evidence againstMagnesium produced no statistically significant difference from placebo in cramp frequency, in the proportion of people achieving a 25% reduction, or in cramp intensity or duration 2.
Studied: A Cochrane review of 11 randomized trials in 735 people, with the idiopathic-cramp analyses largely in older adults.
Limits: This is the strongest negative result on the page. The frequency finding was moderate-certainty and the 25%-reduction finding high-certainty evidence, with minimal heterogeneity 2.
Falling asleep faster
Limited human evidenceSleep onset latency was about 17 minutes shorter than placebo, while the gain in total sleep time was not statistically significant 3.
Studied: Three randomized placebo-controlled trials in 151 older adults with insomnia.
Limits: All three trials were at moderate-to-high risk of bias and the reviewers graded the evidence low to very low quality, concluding the literature is substandard for firm recommendations 3.
Cramps in pregnancy
Not establishedThe pregnancy trials could not be combined, and of three placebo-controlled studies one found no benefit, one found benefit and one reported results that could not be reconciled 2.
Studied: Five trials in 408 pregnant women, all judged at high risk of bias.
Limits: Genuinely unresolved rather than negative, and distinct from the idiopathic-cramp finding above.
The gap between what it is sold for and what it does
Magnesium is marketed most heavily for muscle cramps and sleep. Those are the two outcomes with the weakest support on this page: cramps has a high-certainty negative from Cochrane 2, and sleep rests on three small trials the reviewers themselves described as substandard 3.
Meanwhile the strongest result, blood pressure in hypertensive people and in those already low in magnesium 1, is rarely the reason anyone buys it.
Why the sleep evidence is still worth something
A weak positive is not the same as a negative. The reviewers who graded the magnesium sleep evidence as low quality still landed mildly in favour, and their reasoning is worth borrowing: magnesium is cheap, widely available and safe in ordinary amounts, so the cost of a weak positive turning out to be wrong is small 3.
That is a reasonable basis for trying it. It is not the same as evidence that it works, and the two should not be quoted interchangeably.
Forms and tolerability
The salt on the label matters for two reasons. It determines how much elemental magnesium a capsule contains, so comparing products by the number on the front without checking which figure is quoted produces misleading comparisons. It also determines gastrointestinal tolerability, which is why some magnesium salts are sold as laxatives in their own right.
Marketing claims about the superiority of specific forms generally run ahead of the comparative trial evidence.
How closely our product matches what was studied
MDS Labs sells Pure Magnesium Glycinate at 275 mg elemental. The blood-pressure trials used elemental doses from 82 to 637 mg daily with a median of 365 mg 1, so 275 mg sits inside the studied range and below its midpoint.
Two things are worth stating plainly against that. The blood-pressure effect concentrated in people who were already hypertensive or low in magnesium, and did not reach significance in normotensive groups 1. And for the nocturnal leg cramps magnesium is most often bought to treat, the Cochrane review found no benefit 2.
We sell it because the published research on the compound is worth following, which is a different statement from a claim about what it will do for you.
What we can conclude
If you are hypertensive, on blood-pressure medication, or have been found to be low in magnesium, this is a supplement with a real and reasonably well-measured effect 1. If you are buying it for nocturnal leg cramps, the best available evidence says it will not help 2. If you are buying it to fall asleep faster, the evidence is weak but the risk is low, which is a defensible reason to run your own trial rather than a reason to expect much.
Technical layer: chemistry and pharmacokinetics
Measurement. Serum magnesium is the routinely available test, but most body magnesium is intracellular and in bone, so a normal serum value does not exclude depletion. This is why the blood-pressure subgroup finding in people with documented low magnesium is informative while a general population result is harder to interpret 1.
Dose range in the trials. The blood-pressure analysis covered elemental doses from 82 to 637 mg daily with a median of 365 mg over a median of 12 weeks 1. The sleep trials used quantities under 1 g of magnesium salt given up to three times daily 3.
Interactions. Magnesium salts can interfere with the absorption of several medicines, including some antibiotics, and magnesium handling changes in kidney impairment. Both are reasons to involve a pharmacist rather than to assume a mineral is inert.
